<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00802009</url>
  </required_header>
  <id_info>
    <org_study_id>08-0896-B</org_study_id>
    <nct_id>NCT00802009</nct_id>
  </id_info>
  <brief_title>Dexamethasone and Analgesic Duration After Supraclavicular Brachial Plexus Blockade</brief_title>
  <official_title>Dexamethasone and Analgesic Duration After Supraclavicular Brachial Plexus Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing surgery of the hand often are treated with a nerve block in the
      shoulder/neck area that provides anesthesia/numbing during surgery. Nerve blocks usually last
      for a few hours after surgery and provide pain relief for this period. It may be possible to
      extend the duration of anesthesia by using a steroid, which has anti-inflammtory properties.
      This study will compare the duration of the nerve block when dexamethasone (steroid) is added
      to the anesthetic injected around the nerve.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of anesthesia</measure>
    <time_frame>hourly for first 24 hours; daily until discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Requirements for pain medications; complications</measure>
    <time_frame>up to 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone 8mg added to routine local anesthetic during brachial plexus blockade.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Routine anesthetic solution (30 cc 1.5% mepivicaine) used during brachial plexus blockade.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Dexamethasone 8 milligrams (liquid) will be added to standard anesthetic solution administered during routine brachial plexus nerve blockade.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepivicaine</intervention_name>
    <description>Standard anesthetic solution administered during routine brachial plexus nerve blockade.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients having unilateral hand or forearm surgery under Supraclavicular brachial
             plexus blockade.

          2. ASA I-III

          3. Age 18-60

          4. BMI &lt; 35

        Exclusion Criteria:

          1. Patients with a known history of hypersensitivity to local anesthetics and
             dexamethasone.

          2. Contra-indication to regional anesthesia/ supraclavicular brachial plexus blockade
             e.g. bleeding diathesis, coagulopathy.

          3. Peripheral neuropathy.

          4. Peptic ulcer disease.

          5. Diabetes Mellitus.

          6. Inability to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Toronto Western Hospital, University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6G 2N6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2008</study_first_submitted>
  <study_first_submitted_qc>December 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2008</study_first_posted>
  <last_update_submitted>January 22, 2010</last_update_submitted>
  <last_update_submitted_qc>January 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Richard Brull</name_title>
    <organization>University Health Network</organization>
  </responsible_party>
  <keyword>ultrasound-guided regional anesthesia</keyword>
  <keyword>nerve block</keyword>
  <keyword>brachial plexus</keyword>
  <keyword>mepivicaine</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>hand wrist surgery</keyword>
  <keyword>duration</keyword>
  <keyword>anesthetic duration following brachial plexus/nerve block for hand/wrist surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

